US$ 22.19
bpc-157 clinical trials human dosing Dosage Guide: Protocols & Safety 2026 bpc-157 human clinical trials dosing
Description
Studies support that L-lysine can help decrease the frequency and duration of HSV cold sore outbreaks, by lowering levels of arginine (an amino acid that promotes HSV-1 replication) in the body, consequently suppressing HSV-1 growth

In rat spinal cord compression with tail paralysis, axonal and neuronal necrosis, demyelination, cyst formation, BPC 157 result in marked recovery and rescues tail function in both short-terms and long-terms

2016, doi: 10.18632/oncotarget.11168
Every vial we supply is meticulously manufactured to meet strict safety and efficacy standards , helping protect both healthcare professionals and patients at every stage of medication preparation and use

The Department of Defense prohibits its use by members of the military